06308699 · Active · incorporated 19 years, 2 months ago · Manchester
Medtech Drug Discovery Medical Devices Series B+
Phagenesis develops the Phagenyx System, a medical device for treating neurogenic dysphagia (swallowing disorders).
Phagenesis Limited is a private limited company registered at Companies House under number 06308699, incorporated on 10 July 2007, with a registered office in Manchester. Its current status on the register is active. Its filed nature of business is other research and experimental development on natural sciences and engineering (SIC 72190). Sonde has indexed 154 filings for this company, including 6 funding rounds. Its most recent round closed in April 2026, raising £18.6m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Apr 2026 | £18.6m | £6.80 |
| Round 5 | Aug 2024 | £25.2m | £10.17 |
| Round 4 | Aug 2016 | £6m | £9.03 |
| Round 3 | Apr 2013 | £5m | £11.29 |
| Round 2 | Sep 2011 | £2.2m | £11.29 |
| Round 1 | Jun 2010 | £2.2m | £7.30 |
Showing the 10 most recent of 154 filings.
See the complete cap table with every shareholder, founder tags, dilution across 29 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.